Citius Pharmaceuticals (CTXR) Cash & Equivalents (2010 - 2026)
Citius Pharmaceuticals (CTXR) recorded Cash & Equivalents of $17.01 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 179.3% from $6.09 million a year earlier and up 270.5% from the prior quarter.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals reported Cash & Equivalents of $4.25 million, up 30.8% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -21.0% (FY2020 to FY2025).
- Across earlier fiscal years, Cash & Equivalents came in at $3.25 million in FY2024 (-87.7%), $26.48 million in FY2023 (-36.5%), $41.71 million in FY2022 (-40.5%) and $70.07 million in FY2021 (+405.6%).
- The fiscal Q3 2026 figure is the highest quarterly Cash & Equivalents since fiscal Q3 2024.
- On a year-over-year basis, Cash & Equivalents rose in three of the last seven quarters, with growth averaging 66.3%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 601.9% in fiscal Q1 2026, against a decline of 99.8% in fiscal Q2 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $4.59 million (Q2 2026), $7.72 million (Q1 2026) and $4.25 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Citius Pharmaceuticals | 10.47 Mn | -23.10 Mn | 1.00 Mn | 17.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.01 Mn |
| Mar 31, 2026 | 4.59 Mn |
| Dec 31, 2025 | 7.72 Mn |
| Sep 30, 2025 | 4.25 Mn |
| Jun 30, 2025 | 6.09 Mn |
| Mar 31, 2025 | 26,410.00 |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 3.25 Mn |
| Jun 30, 2024 | 17.91 Mn |
| Mar 31, 2024 | 12.56 Mn |
| Dec 31, 2023 | 20.35 Mn |
| Sep 30, 2023 | 26.48 Mn |
| Jun 30, 2023 | 33.28 Mn |
| Mar 31, 2023 | 29.07 Mn |
| Dec 31, 2022 | 36.89 Mn |
| Sep 30, 2022 | 41.71 Mn |
| Jun 30, 2022 | 48.04 Mn |
| Mar 31, 2022 | 55.76 Mn |
| Dec 31, 2021 | 65.42 Mn |
| Sep 30, 2021 | 70.07 Mn |
API Access
Citius Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();